Novartis names Harvard's Bradner head of biomedical research

September 24, 2015 4:16 PM

30 0

ZURICH, Sept 24 Novartis on Thursday named Harvard Medical School cancer specialist James Bradner as head of biomedical research with a seat on its executive committee as of March 2016.

Bradner succeeds Mark Fishman, who is retiring after a 13-year stint leading the Swiss company's drug discovery and early clinical development efforts.

Also read: Dikembe Mutombo to receive Sager Strong Award for humanitarian work

Read more

To category page